Sale!

SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SYNE1 gene plays a crucial role in Emery-Dreifuss Muscular Dystrophy type 4 (EDMD4), a condition characterized by muscle weakness, contractures, and cardiac abnormalities. Testing for mutations in the SYNE1 gene is critical for the diagnosis and management of EDMD4. DNA Labs UAE offers a genetic test specifically designed to detect mutations in the SYNE1 gene, providing essential information for patients and their families regarding prognosis, treatment options, and genetic counseling. The cost of this comprehensive test is 4400 AED. Conducted in a state-of-the-art laboratory setting, the test ensures accuracy and reliability, offering valuable insights into this rare genetic disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test

At DNA Labs UAE, we offer the SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test. This test is designed to detect mutations in the SYNE1 gene, which is associated with Emery-Dreifuss muscular dystrophy type 4.

Test Components and Price

The cost of the SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test is AED 4400.0. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

Once the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS technology, which stands for Next-Generation Sequencing. This advanced sequencing method allows for the analysis of multiple genes simultaneously.

Test Type and Doctor

The SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this specific test.

Test Department and Pre Test Information

The test is conducted in our Genetics department. Before undergoing the SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the disorder.

About Emery-Dreifuss Muscular Dystrophy Type 4

Emery-Dreifuss muscular dystrophy type 4 is a rare inherited disorder that affects muscle function and movement. It is caused by mutations in the SYNE1 gene, which provides instructions for making a protein called nesprin-1. Nesprin-1 is responsible for maintaining the structure and function of muscle cells.

Benefits of Genetic Testing

Genetic testing using NGS technology can help confirm the diagnosis of Emery-Dreifuss muscular dystrophy type 4 and provide information about the specific mutation involved. This information is crucial for guiding treatment and management of the disorder.

Individual Circumstances and Medical History

It is important to note that genetic testing may not be necessary or appropriate for everyone with Emery-Dreifuss muscular dystrophy type 4. A healthcare provider, such as a Neurologist, can help determine if genetic testing is recommended based on the individual’s circumstances and medical history.

Test Name SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SYNE1 Gene Emery-Dreifuss muscular dystrophy type 4
Test Details

The SYNE1 gene is associated with Emery-Dreifuss muscular dystrophy type 4, which is a rare inherited disorder that affects muscle function and movement. This disorder is caused by mutations in the SYNE1 gene, which provides instructions for making a protein called nesprin-1. Nesprin-1 is involved in maintaining the structure and function of muscle cells.

NGS genetic testing is a type of genetic test that uses next-generation sequencing technology to analyze multiple genes simultaneously. This type of testing can detect mutations in the SYNE1 gene and other genes associated with muscular dystrophy.

If a person is suspected of having Emery-Dreifuss muscular dystrophy type 4, genetic testing can help confirm the diagnosis and provide information about the specific mutation involved. This information can be used to guide treatment and management of the disorder.

It is important to note that genetic testing is not always necessary or appropriate for everyone with Emery-Dreifuss muscular dystrophy type 4. A healthcare provider can help determine if genetic testing is recommended based on a person’s individual circumstances and medical history.